Article ID Journal Published Year Pages File Type
9237784 Digestive and Liver Disease 2005 4 Pages PDF
Abstract
We describe the case of a patient who developed acute hepatitis C virus infection and, while receiving pegylated interferon alpha-2b monotherapy, developed a severe polymyositis. This case illustrates the potential risk of autoimmunity by interferon, also for acute hepatitis, and underlines the importance of a prompt diagnosis and a rapid discontinuation of interferon treatment for an improvement of clinical outcomes.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Endocrinology, Diabetes and Metabolism
Preview
Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b
Authors
, , , , ,